In estrogen receptor–positive breast cancer, ZIF-8 nanoparticles were employed to co-deliver antisense oligonucleotides (ASOs) targeting circTNK2 and plasmids encoding CXCL10 (101, 157). This evidence concerns the gene CXCL10 and breast cancer.